Hosted on MSN21h
60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trialUS-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback